Genomics Risk Assessment For Cancer & Early Detection (GRACE) Program
Risk Pathways, Risk Assessment, Health System
Description
The GRACE program brings together digital mammography and AI to give patients a clearer picture of their breast cancer risk. As the first program of its kind in Florida, it helps clinicians spot potential risk earlier and support more personalized care.
The innovative GRACE program is reshaping breast cancer risk assessment powered by Risk Pathways™.
In this article, learn how AdventHealth recently began piloting a new Genomics Risk Assessment for Cancer and Early Detection (GRACE) program. The first program of its kind in Florida, GRACE combines the use of digital mammography, artificial intelligence (AI) technology and embedded algorithms to assess a patient’s potential risk of developing breast cancer.
Discover how Risk Pathways simplifies breast, endometrial, ovarian, colorectal, pancreatic and prostate cancer risk assessment to support smarter clinical decisions so you can focus on delivering personalized care
